Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Plugs for containing faecal incontinence.

Deutekom M, Dobben AC.

Cochrane Database Syst Rev. 2015 Jul 20;7:CD005086. doi: 10.1002/14651858.CD005086.pub4. Review.

PMID:
26193665
2.

Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer.

Denters MJ, Bossuyt PM, Deutekom M, Fockens P, Dekker E.

Eur J Cancer Prev. 2015 May;24(3):176-9. doi: 10.1097/CEJ.0000000000000139.

PMID:
25734239
3.

A poor association was found between self-reported physical activity and estimated maximal oxygen uptake of sedentary multiethnic women.

Gademan MG, Hosper K, Deutekom M, Engelbert RH, Myers J, Stronks K.

J Clin Epidemiol. 2014 Apr;67(4):462-7. doi: 10.1016/j.jclinepi.2013.11.004.

PMID:
24581298
4.

FIT false-positives in colorectal cancer screening experience psychological distress up to 6 weeks after colonoscopy.

Denters MJ, Deutekom M, Essink-Bot ML, Bossuyt PM, Fockens P, Dekker E.

Support Care Cancer. 2013 Oct;21(10):2809-15. doi: 10.1007/s00520-013-1867-7. Epub 2013 Jun 1.

PMID:
23729229
5.

Patients' perception of colonoscopy: patients with inflammatory bowel disease and irritable bowel syndrome experience the largest burden.

Denters MJ, Schreuder M, Depla AC, Mallant-Hent RC, van Kouwen MC, Deutekom M, Bossuyt PM, Fockens P, Dekker E.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):964-72. doi: 10.1097/MEG.0b013e328361dcd3.

PMID:
23660935
6.

Patient burden of colonoscopy after positive fecal immunochemical testing for colorectal cancer screening.

Denters MJ, Deutekom M, Bossuyt PM, Fockens P, Dekker E.

Endoscopy. 2013;45(5):342-9. doi: 10.1055/s-0032-1326238. Epub 2013 Mar 12.

PMID:
23483433
7.

Assessing knowledge and attitudes towards screening among users of faecal immunochemical test.

Denters MJ, Deutekom M, Essink-Bot ML, Bossuyt PM, Fockens P, Dekker E.

Health Expect. 2013 Feb 25. doi: 10.1111/hex.12056. [Epub ahead of print]

PMID:
23432931
8.

Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.

Denters MJ, Deutekom M, Bossuyt PM, van Rijn AF, Fockens P, Dekker E.

Cancer Epidemiol. 2013 Jun;37(3):330-5. doi: 10.1016/j.canep.2013.01.007. Epub 2013 Feb 9.

PMID:
23403127
9.

A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.

Denters MJ, Deutekom M, Bossuyt PM, Fockens P, Dekker E.

Eur J Cancer Prev. 2013 Jul;22(4):299-304. doi: 10.1097/CEJ.0b013e32835b3882.

PMID:
23169243
10.

Inappropriate use of the faecal occult blood test in a university hospital in the Netherlands.

van Rijn AF, Stroobants AK, Deutekom M, Lauppe C, Sturk A, Bossuyt PM, Fockens P, Dekker E.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1266-9.

PMID:
23022920
11.

The effect of exercise on prescription on physical activity and wellbeing in a multi-ethnic female population: A controlled trial.

Gademan MG, Deutekom M, Hosper K, Stronks K.

BMC Public Health. 2012 Sep 10;12:758. doi: 10.1186/1471-2458-12-758.

12.

Plugs for containing faecal incontinence.

Deutekom M, Dobben AC.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD005086. doi: 10.1002/14651858.CD005086.pub3. Review.

PMID:
22513927
13.

Effectiveness of a web-based health risk assessment with individually-tailored feedback on lifestyle behaviour: study protocol.

Laan EK, Kraaijenhagen RA, Peek N, Busschers WB, Deutekom M, Bossuyt PM, Stronks K, Essink-Bot ML.

BMC Public Health. 2012 Mar 19;12:200. doi: 10.1186/1471-2458-12-200.

14.

Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.

Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.

Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.

PMID:
22108194
15.

The effects of screening on health behaviour: a summary of the results of randomized controlled trials.

Deutekom M, Vansenne F, McCaffery K, Essink-Bot ML, Stronks K, Bossuyt PM.

J Public Health (Oxf). 2011 Mar;33(1):71-9. doi: 10.1093/pubmed/fdq050. Epub 2010 Jul 28. Review.

16.

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.

Deutekom M, van Rossum LG, van Rijn AF, Laheij RJ, Fockens P, Bossuyt PM, Dekker E, Jansen JB.

Scand J Gastroenterol. 2010 Nov;45(11):1345-9. doi: 10.3109/00365521.2010.497937. Epub 2010 Jun 21.

PMID:
20560814
17.

Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial.

de Wijkerslooth TR, de Haan MC, Stoop EM, Deutekom M, Fockens P, Bossuyt PM, Thomeer M, van Ballegooijen M, Essink-Bot ML, van Leerdam ME, Kuipers EJ, Dekker E, Stoker J.

BMC Gastroenterol. 2010 May 19;10:47. doi: 10.1186/1471-230X-10-47.

18.

Inconclusive psychometric properties of the Vaizey score in fecally incontinent patients: a prospective cohort study.

Bols EM, Hendriks EJ, Deutekom M, Berghmans BC, Baeten CG, de Bie RA.

Neurourol Urodyn. 2010 Mar;29(3):370-7. doi: 10.1002/nau.20758.

PMID:
19634170
19.

Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.

Denters MJ, Deutekom M, Fockens P, Bossuyt PM, Dekker E.

BMC Gastroenterol. 2009 Apr 24;9:28. doi: 10.1186/1471-230X-9-28.

20.

Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands.

Deutekom M, van Rijn AF, Dekker E, Blaauwgeers H, Stronks K, Fockens P, Essink-Bot ML.

Eur J Public Health. 2009 Aug;19(4):400-2. doi: 10.1093/eurpub/ckp051. Epub 2009 Apr 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk